Novartis Patient Support is a program designed to help your eligible patients start, stay, and save on SCEMBLIX.

Access to a Novartis Patient Support team committed to providing the support you need, including:

• Dedicated assistance with access and reimbursement

• Personalized support for your patients on therapy

• Single points of contact for you and your patients

We support you throughout your patient’s journey with:

Insurance Support

Help navigating the insurance process, including benefits verification and support with the prior authorization and appeals processes.

Benefits Verification
Once you’ve enrolled your patients in Novartis Patient Support, our team will conduct a benefits verification to help you better understand your patient’s coverage, including:

• Inform your practice about additional requirements, such as prior authorization

• Identify savings options available to your patients

Prior Authorizations (PAs) and Appeals
Novartis Patient Support can help with PA requests or letters of appeal by working directly with you or your office, including:

• Provide best practices and timely updates via phone

• Access and Support Guide that includes the following:

  • PA Checklist

  • Exception Request Checklist

  • Peer-to-Peer Checklist

  • Appeals Submission Checklist

  • Sample Letters

Financial Support

Assist with connecting patients to relevant saving options.

To sign up for the $0 Co-Pay Plus offer:

*Limitations apply. Valid only for those with private insurance. The Program includes the Co-Pay Plus offer, Plus Card (if applicable), and Rebate, with a combined annual limit up to $15,000. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient’s insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient’s insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.

Other Affordability Assistance

30-day Free Trial Offer

Available to all patients who have a valid prescription^† for SCEMBLIX, regardless of insurance. 

With our 30-day Free Trial Offer,^† patients can start on SCEMBLIX today and see if it might be right for them.

Download the 30-day Free Trial Offer

^†No purchase required. This free trial is not health insurance. Void where prohibited by law. Product dispensed pursuant to terms and conditions of offer. Valid only in the US and Puerto Rico. Claims shall not be submitted to any public or private third-party payer or any federal or state health care program for reimbursement. Offer not valid if reproduced or submitted to any other payer. It is illegal for any person to sell, purchase or trade, or offer to sell, purchase or trade, or to counterfeit, this offer. Prescriber ID# is required on prescription. This is the property of Novartis Pharmaceuticals Corporation and must be returned upon request. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend this offer without notice.

The Novartis Patient Assistance Foundation, Inc. (NPAF) 

If uninsured or underinsured patients express financial hardship, Novartis Patient Support can help connect them with Novartis Patient Assistance Foundation (NPAF). NPAF is an independent 501(c)(3) non-profit, non-commercial entity. Patients who cannot afford the cost of their Novartis medication may be eligible to receive them from NPAF at no cost.

NPAF is committed to providing access to Novartis medications for those most in need. To be eligible, a patient must:

• Reside in the United States or a U.S. Territory

• Have limited or no prescription insurance coverage

• Meet income guidelines for the medication for which the patient is seeking assistance

• Have a valid prescription for the Novartis medication

• Be treated by a licensed U.S. healthcare provider on an outpatient basis

Questions?

For more information on NPAF call 1-800-277-2254, then select option 2 for a dedicated prescriber line Monday-Friday from 8:00 AM-8:00 PM ET, or visit www.PAP.Novartis.com for more information.

Ongoing Support

Novartis Patient Support provides patients with ongoing help to stay on track with their SCEMBLIX treatment plan, including:

• A dedicated Novartis Patient Support Team member to answer questions at every step

• Information on financial support options

• Help navigating health care changes

• Tips for setting up a routine that can help patients stay on track with their medication dosing

• Educational resources about SCEMBLIX and living with Ph+ CML-CP and Ph+ CML in CP with the T315I mutation

  • A guide to help them start treatment with SCEMBLIX

  • A brochure that can help them find answers to many of their questions

  • Tips for talking to their health care provider

• Their choice of texts, calls, and emails, including tips to keep them on track

Getting Patients Started with Novartis Patient Support

CoverMyMeds is a registered trademark of CoverMyMeds LLC.
 

Resources

Novartis Patient Support has helpful resources to support you and your practice throughout your patient’s treatment journey.

Specialty Pharmacy Network

The specialty pharmacies (SPs) listed below are authorized to dispense SCEMBLIX in the United States and in US territories. These SPs can service most commercial and Medicare Part D plans.

These network pharmacies can help providers manage the prior authorization process and provide eligible patients with information about co-pay support options, patient support programs, and additional resources.

Biologics by McKesson 

• Website: www.biologics.mckesson.com ↗

• Phone: 1-800-850-4306

• Fax: 1-800-823-4506

Onco360^® Oncology Pharmacy 

• Website: www.onco360.com ↗

• Phone: 1-877-662-6633

• Fax: 1-877-662-6355

The following specialty distributors are authorized to distribute SCEMBLIX to eligible in-office dispensing practices, institutions, and hospitals.

Cencora 

• Website: asdhealthcare.com ↗

• Phone: 1-800-746-6273

• Fax: 1-800-547-9413

Cardinal Health 

• Website: specialtyonline.cardinalhealth.com ↗

• Phone: 1-855-855-0708

• Fax: 1-614-553-6301

McKesson Plasma and Biologics 

• Website: connect.mckesson.com ↗

• Phone: 1-877-625-2566

• Fax: 1-888-752-7626

McKesson Specialty 

• Website: mscs.mckesson.com ↗

• Phone: 

  • Oncology: 1-800-482-6700

  • Other Specialties: 1-855-477-9800

• Fax: 1-800-800-5673

Provided for informational purposes only and is subject to change. Novartis does not endorse the use of any specific listed distributors.

Ensure drug routing and administration records are correct

For Example:

• NDC: 0078-1091-20, 0078-1098-20, 0078-1196-20

• Dosage

• Route of Administration: Oral

• Order Class: Specialty pharmacies

• When configuring SCEMBLIX in your electronic health record (EHR), ensure the routing is correctly configured

• Configure SCEMBLIX to be distributed via specialty pharmacies (Biologics and Onco360)

• Configure the medication record on the specific drug itself to restrict available pharmacies to Biologics or Onco360, in-office dispensing pharmacy, and select health system pharmacies that are able to dispense the medication